UK Clinical Trial Biorepository & Archiving Solutions Market Size & Outlook

The clinical trial biorepository & archiving solutions market in UK is expected to reach a projected revenue of US$ 477.6 million by 2030. A compound annual growth rate of 7.7% is expected of UK clinical trial biorepository & archiving solutions market from 2024 to 2030.
Revenue, 2023 (US$M)
$284.5
Forecast, 2030 (US$M)
$477.6
CAGR, 2024 - 2030
7.7%
Report Coverage
UK

UK clinical trial biorepository & archiving solutions market, 2018-2030 (US$M)

UK
Unlock Premium

Related Markets

UK clinical trial biorepository & archiving solutions market highlights

  • The UK clinical trial biorepository & archiving solutions market generated a revenue of USD 284.5 million in 2023 and is expected to reach USD 477.6 million by 2030.
  • The UK market is expected to grow at a CAGR of 7.7% from 2024 to 2030.
  • In terms of segment, biorepository services was the largest revenue generating service in 2023.
  • Biorepository Services is the most lucrative service segment registering the fastest growth during the forecast period.


Clinical trial biorepository & archiving solutions market data book summary

Market revenue in 2023USD 284.5 million
Market revenue in 2030USD 477.6 million
Growth rate7.7% (CAGR from 2023 to 2030)
Largest segmentBiorepository services
Fastest growing segmentBiorepository Services
Historical data2018 - 2022
Base year2023
Forecast period2024 - 2030
Quantitative unitsRevenue in USD million
Market segmentationBiorepository Services, Archiving Solution Services
Key market players worldwideAzenta Inc, Thermo Fisher Scientific Inc, Precision for Medicine, Medpace Holdings Inc, Labcorp Drug Development, ATCC, Q2 Solutions, LabConnect, Charles River Laboratories International Inc


Other key industry trends

  • In terms of revenue, UK accounted for 7.1% of the global clinical trial biorepository & archiving solutions market in 2023.
  • Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
  • In Europe, France clinical trial biorepository & archiving solutions market is projected to lead the regional market in terms of revenue in 2030.
  • UK is the fastest growing regional market in Europe and is projected to reach USD 477.6 million by 2030.

Biorepository services was the largest segment with a revenue share of 66.36% in 2023. Horizon Databook has segmented the UK clinical trial biorepository & archiving solutions market based on biorepository services, archiving solution services covering the revenue growth of each sub-segment from 2018 to 2030.


The UK is one of the major hubs for biopharmaceuticals companies based in Europe, such as GlaxoSmithKline plc, AstraZeneca, & Novartis, and all clinical trial biorepository & archiving solution providers across Europe have some part of their supply chain going through the UK.

Major clinical supply service players such as DHL, PCI, Alamac, Fisher clinical, and Catalent have distribution and packaging centers in the UK, which provide services across Europe.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Clinical Trial Biorepository & Archiving Solutions Market Companies

Name Profile # Employees HQ Website

UK clinical trial biorepository & archiving solutions market size, by service, 2018-2030 (US$M)

UK Clinical Trial Biorepository & Archiving Solutions Market Outlook Share, 2023 & 2030 (US$M)

UK clinical trial biorepository & archiving solutions market size, by service, 2018-2030 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more